Clinical Trial Update: A Multicenter, Randomized, Placebo-Controlled Phase 2 Study to Evaluate the Clinical Efficacy, Safety, and Tolerability of ARX-F01 Sublingual Sufentanil in Patients Undergoing Major Abdominal Surgery [Phase 2]

View source ↗

Summary

A multicenter randomized, placebo-controlled Phase 2 trial evaluating the efficacy, safety, and tolerability of ARX-F01 Sublingual Sufentanil for postoperative …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain

Drugs mentioned

• ARX-F01 Sublingual Sufentanil (sufentanil)

Snippet

Sponsor: Talphera, Inc | Conditions: Major Upper or Lower Abdominal Surgery | Phase 2 | Status: COMPLETED | Results posted: 2015-01-22